Modern drug discovery utilizes multidisciplinary project teams and attempts to simultaneously move forward with as many aspects of the overall drug discovery and development process as possible. This environment requires that scientists not only be deeply trained in their area of specialty, but also possess a broad background, vocabulary, and appreciation of the possibilities and limitations of related disciplines. This professional certificate is designed to help meet that need. To help students gain a greater understanding of the pharmaceutical industry, the core curriculum includes key background material in biology or chemistry and a general overview of the drug discovery and development process. The addition of electives allows the student to round out their certificate education with courses that are most appropriate to their current or future career needs.
|Course Title||Course Number||Units||FA||WI||SP||SU|
|Preclinical Drug Discovery & Development|
|Introduction to Pharmacology||X|
|Medicinal Chemistry of Leading Drugs||X|
|Predicting & Selecting Promising Drug Compounds||X||O||O|
|Target Identification & Validation|
|ELECTIVE COURSES (A total of 5 units required.)|
|Dosage Form Design and Development|
|High Throughput Screening Methods in Drug Development||X|
|Medicinal Chemistry Intensive Program||X|
|Molecular Diagnostics and Personalized Medicine||X||X|
|Overview of the Drug Development Process||O|
|Stem Cell Biology||O||O|
|Writing Preclinical Reports for IND Submissions|
|L=La Jolla M=Mission Valley O=Online U=University City X=Location TBA|
Certificate registration is required to complete the program. Candidates are encouraged to register in the certificate program as early as possible to take advantage of program benefits. See Certificate FAQs for more information.
|Certificate Section ID:||100483||Add to Cart|
|Contact:||Life Sciences, (858) 534-9353|
This certificate is intended for individuals with educational backgrounds in chemical and biological sciences at the bachelor, masters, or Ph.D. level interested in entering or becoming more effective at working in the pharmaceutical or biotechnology industry.
President and Founder
Human BioMolecular Research Institute
Dan DiSepio, Ph.D.
Principal Scientist, Group Leader, Development
Johnson & Johnson PRD
Grace Furman, Ph.D.
CEO & President
Jelveh Lameh, Ph.D.
Director, BioPharma Services
Ajay Madan, Ph.D., DABT
Sr. Director, Development
Nicholas F. Paoni, Ph.D.
John Saunders, Ph.D.
Vice President Medicinal Chemistry
Robert Ternansky, Ph.D.